Xenazine tetrabenazine regulatory update

FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Dec. 6 to discuss an NDA from Prestwick Pharmaceuticals Inc. (Washington, D.C.) for Xenazine tetrabenazine to treat c...